Cargando…

Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas

The outcome of periampullary adenocarcinomas remains poor with few treatment options. Podocalyxin-like protein (PODXL) is an anti-adhesive protein, the high expression of which has been shown to confer a poor prognosis in numerous malignancies. A correlation and adverse prognostic synergy between PO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heby, Margareta, Karnevi, Emelie, Elebro, Jacob, Nodin, Björn, Eberhard, Jakob, Saukkonen, Kapo, Hagström, Jaana, Mustonen, Harri, Seppänen, Hanna, Haglund, Caj, Jirström, Karin, Larsson, Anna H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316735/ https://www.ncbi.nlm.nih.gov/pubmed/32587323 http://dx.doi.org/10.1038/s41598-020-67187-z

Ejemplares similares

Prognostic and predictive significance of podocalyxin-like protein expression in pancreatic and periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2015)

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2015)

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2016)

Mutational Landscape in Resected Periampullary Adenocarcinoma: Relationship With Morphology and Clinical Outcome
por: Lundgren, Sebastian, et al.
Publicado: (2019)

Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma
por: Heby, Margareta, et al.
Publicado: (2018)

Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer
por: Elebro, Jacob, et al.
Publicado: (2016)

Chemotherapy, host response and molecular dynamics in periampullary cancer: the CHAMP study
por: Hau, Sofie Olsson, et al.
Publicado: (2020)

Clinical significance of stromal ER and PR expression in periampullary adenocarcinoma
por: Andersson, Gustav, et al.
Publicado: (2019)

The clinical importance of tumour-infiltrating macrophages and dendritic cells in periampullary adenocarcinoma differs by morphological subtype
por: Lundgren, Sebastian, et al.
Publicado: (2017)

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer
por: Eurola, Annika, et al.
Publicado: (2021)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Podocalyxin is a marker of poor prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
por: Larsson, Anna H., et al.
Publicado: (2016)

PROX1 and β-catenin are prognostic markers in pancreatic ductal adenocarcinoma
por: Saukkonen, Kapo, et al.
Publicado: (2016)

Reduced Expression of the Polymeric Immunoglobulin Receptor in Pancreatic and Periampullary Adenocarcinoma Signifies Tumour Progression and Poor Prognosis
por: Fristedt, Richard, et al.
Publicado: (2014)

The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment
por: Lundgren, Sebastian, et al.
Publicado: (2016)

Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
por: Karnevi, Emelie, et al.
Publicado: (2017)

Topographical Distribution and Spatial Interactions of Innate and Semi-Innate Immune Cells in Pancreatic and Other Periampullary Adenocarcinoma
por: Lundgren, Sebastian, et al.
Publicado: (2020)

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma
por: Hedner, Charlotta, et al.
Publicado: (2016)

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer
por: Lanki, Mira, et al.
Publicado: (2019)

Podocalyxin as a Prognostic Marker in Gastric Cancer
por: Laitinen, Alli, et al.
Publicado: (2015)

The expression and prognostic value of toll-like receptors (TLRs) in pancreatic cancer patients treated with neoadjuvant therapy
por: Nurmi, Anna Maria, et al.
Publicado: (2022)

Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
por: Borg, David, et al.
Publicado: (2016)

Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
por: Larsson, Anna H, et al.
Publicado: (2013)

Matrix Metalloproteinase 8 Expression in a Tumour Predicts a Favourable Prognosis in Pancreatic Ductal Adenocarcinoma
por: Kaasinen, Mirjami, et al.
Publicado: (2022)

The possible dual role of Ang-2 in the prognosis of pancreatic cancer
por: Roos-Mattila, Matilda, et al.
Publicado: (2023)

PRR11 unveiled as a top candidate biomarker within the RBM3‐regulated transcriptome in pancreatic cancer
por: Olsson Hau, Sofie, et al.
Publicado: (2021)

Overexpression of podocalyxin-like protein is an independent factor of poor prognosis in colorectal cancer
por: Larsson, A, et al.
Publicado: (2011)

REG4 Independently Predicts Better Prognosis in Non-Mucinous Colorectal Cancer
por: Kaprio, Tuomas, et al.
Publicado: (2014)

The prognostic role of tissue TLR2 and TLR4 in colorectal cancer
por: Beilmann-Lehtonen, Ines, et al.
Publicado: (2020)

Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer
por: Boman, K, et al.
Publicado: (2013)

Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
por: Borg, David, et al.
Publicado: (2018)

A comparative study of two PODXL antibodies in 840 colorectal cancer patients
por: Kaprio, Tuomas, et al.
Publicado: (2014)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
por: Larsson, Anna, et al.
Publicado: (2012)

Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer
por: Kaprio, Tuomas, et al.
Publicado: (2019)

N-glycosylation in non-invasive and invasive intraductal papillary mucinous neoplasm
por: Nieminen, Heini, et al.
Publicado: (2023)

The Prognostic Importance of CD20(+) B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets
por: Edin, Sofia, et al.
Publicado: (2019)

Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis
por: Arpalahti, Leena, et al.
Publicado: (2018)

Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma
por: Mattila, Nora, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h3uulfacundv1qng85kb651dj6